Patient-reported outcomes from two global multicenter clinical trials of children and adults with tropomyosin receptor kinase (TRK) fusion cancer receiving larotrectinib Meeting Abstract


Authors: Kummar, S.; Mascarenhas, L.; Geoerger, B.; Turpin, B.; Cox, M. C.; Yu, S.; Nanda, S.; Hiemeyer, F.; Keating, K. N.; Chirila, C.; Gnanasakthy, A.; Davenport, E.; Hong, D. S.; Drilon, A. E.
Abstract Title: Patient-reported outcomes from two global multicenter clinical trials of children and adults with tropomyosin receptor kinase (TRK) fusion cancer receiving larotrectinib
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 392s
Language: English
ACCESSION: WOS:000487345806156
DOI: 10.1200/JCO.2019.37.15_suppl.6602
PROVIDER: wos
Notes: Meeting Abstract: 6602 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon